296
Participants
Start Date
November 3, 2005
Primary Completion Date
July 4, 2008
Study Completion Date
January 10, 2013
carboplatin
Given IV
cediranib maleate
Given orally
paclitaxel
Given IV
placebo
Given orally
Instituto Alexander Fleming, Buenos Aires
Compleso Medico de la Policia Federal Argentina, Buenos Aires
Clinical County Hospital of Sibiu, Sibiu
Alfred Hospital, Melbourne
"Oncological Institute Ion Chiricuta", Cluj-Napoca
National University Hospital, Singapore
Hospital Universitario Austral, Buenos Aires
Instituto Nacional de Cancer (INCA), Rio de Janeiro
Cross Cancer Institute, Edmonton
BCCA - Vancouver Cancer Centre, Vancouver
Northeast Cancer Center Health Sciences, Greater Sudbury
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
London Regional Cancer Program, London
Ottawa Health Research Institute - General Division, Ottawa
Algoma District Cancer Program, Sault Ste. Marie
Niagara Health System, St. Catharines
Mount Sinai Hospital, Toronto
Univ. Health Network-Princess Margaret Hospital, Toronto
University Institute of Cardiology and, Québec
Oncology Institute Bucharest, Bucharest
Lead Sponsor
NCIC Clinical Trials Group
NETWORK